About
Kexiang Zhou received his Doctor’s degree from Peking University Health Science Center. He is a venture capitalist and entrepreneur in the healthcare space for more than 20 years. Currently serves as Managing director of CMB International healthcare investment. Under Kexiang Zhou’s leadership, CMBI healthcare team has invested over 1.5 billion RMB in more than 10 projects, with focus on gene technology, innovative drugs, medical instruments, generic drugs, etc. Former Deputy general manager of Guangzhou Pharmaceutical Holdings (“GPH”) and President of BaiYunShan General Factory (“BYS”), a public listed subsidiary of GPH, where he was responsible for the company’s R&D, production, quality control in the pharmaceutical sector, as well as the company’s international business and intermediates sector. During his stay, Kexiang Zhou has formed and developed the world largest medical commercial joint venture. Previously as a managing director and the chairman of investment committee in hea
Position in the VCSift Database
- • 1,801 investors hold the Managing Director role in VCSift. Kexiang Zhou is one of them.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
Contact Information
Find more investors like Kexiang
Search Investors